Subscribe to our Newsletters !!
Out there, in the fossil beds of Illinois, imposin
The moment you put a spoon of sugar into water and
This doesn't feel like another one of my English e
New Delhi, India – April 27, 2025 - An Indian co
Alembic Pharmaceuticals Limited (Alembic) announce
'Simplicity' seems to be the perfect word to descr
Dear Readers, Welcome to the latest issue of The Magazine
New Delhi, India – April 27, 2025 – An Indian company producing histopathology laboratory equipment,Unimeditrek Pvt. Ltd, has received a FDA clearance for their entire line of diagnostic equipment, which is a major milestone for the management of cancer and other deadly diseases in India.
Now, with this accreditation, Unimeditrek products are accepted globally to international marks, making Indian hospitals accessible to world-class, cost-efficient, and safe histopathology services. Such technology is very important for the early and accurate diagnosis of cancer whereby timely treatment increases the chances of improving the patient’s condition and prolonging their life.
The FDA approval spans across Unimeditrek’s flagship line of histopathology equipment, including:
Together, these instruments assist hospitals in producing precise, high-resolution pathology slides—a requirement in cancer, infection, and autoimmune disease diagnosis.
Traditionally, Indian hospitals have relied on externally imported histopathology systems, which are expensive and less available to smaller diagnostic labs and clinics, especially in Tier 2 and Tier 3 cities. FDA clearance for Unimeditrek now provides an indigenously produced substitute that combines global quality and national affordability, making early cancer screening and other pathology services accessible across the country.
“With this approval by the FDA, we’re delighted to present Indian hospitals with the equipment used to diagnose cancer and other illnesses with a consistency and accuracy competing with the highest foreign systems,” stated a representative for Unimeditrek. “This represents a significant development not only for our firm but for the overall Indian healthcare infrastructure.”
Director’s Desk brings the powerful insights of Mr. Rishu Arora, Director of Unimeditrek Pvt. Ltd. On behalf of FDA, this has been a tremendous achievement for them. It substantiates the indomitable effort to provide low-cost diagnostic solutions on par with the best in the world; it also enables Indian hospitals to have the infrastructure for treating cancers and other life-threatening conditions. I am pleased that the goals set forth by our team have been accomplished. This brings us closer to our vision as we strive to enhance the value for life by affordable medical care for all Indians. This achievement is bound to set higher standards internationally and make a difference to the quality of life through innovation in technology and medicine.
In addition to equipment, Unimeditrek also offers an extensive range of accessories and consumables such as microtome blades, biopsy cassettes, reagents, and protective gear—all available on its website www.unilabequipments.com . Unimeditrek Pvt. Ltd., a New Delhi company, is committed to revolutionizing India’s diagnostic labs with high-quality, affordable histopathology equipment. Blending innovation with global compliance standards, Unimeditrek enables healthcare providers to offer quicker, more accurate diagnostics to every patient—regardless of geography or income level.
